# Dose De-escalation in Prostate Radiotherapy Using the MRL

> **NCT05709496** · NA · RECRUITING · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 20 (estimated)

## Conditions studied

- Prostate Adenocarcinoma

## Interventions

- **RADIATION:** De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac

## Key facts

- **NCT ID:** NCT05709496
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05709496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05709496, "Dose De-escalation in Prostate Radiotherapy Using the MRL". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05709496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*